Genenta Science S.p.A (GNTA) Operating Expenses (2022)
Genenta Science S.p.A (GNTA) posted Operating Expenses of $1.5 million for Q2 2022.
Genenta Science S.p.A (GNTA) Operating Expenses (2022) Analysis & Trends
Genenta Science S.p.A has reported Operating Expenses for 1 years, with the latest figure at $1.5 million in Q2 2022.
- Quarterly Operating Expenses changed N/A year-over-year to $1.5 million in Q2 2022, while the trailing twelve-month figure through Dec 2023 was $1.5 million (changed 0.0% YoY) and the FY2025 annual result came in at $7.7 million, down 26.33% from the prior year.
- Operating Expenses held at $1.5 million in Q2 2022 per GNTA's latest filing.
- Over five years, Operating Expenses peaked at $1.5 million in Q2 2022 and troughed at $1.5 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 541.02 Mn |
| 10 | Genenta Science S.p.A | 24.54 Mn | -34.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 1.46 Mn |